Urology · Latrobe, PA
NPI
1346345980
Since 2006
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
911 Ligonier St Ste 104
Latrobe, PA, 15650
Phone (724) 539-9736
Groups this clinician bills Medicare through
Medicare paid, 2024
$254K
6,268 services
Medicare patients, 2024
564
Average age 75
Drug cost, 2024
$11.9M
3,646 prescriptions
Company payments, 2025
$1,126
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Geoffrey J Bisignani was code J1952 (leuprolide injectable, camcevi, 1 mg), 966 times for 13 patients. In total Geoffrey J Bisignani billed 6,268 services in 65 codes, and Medicare paid $254K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-05-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 966 | 13 | $45.25 | $44K |
| 87798 Infectious Agent Detection by DNA/RNA | Office | 455 | 31 | $34.39 | $16K |
| 99214 Office E&M - Established | Office | 436 | 308 | $89.49 | $39K |
| 81002 Clinical Chemistry | Office | 344 | 259 | $3.41 | $1,173 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 334 | 239 | $12.40 | $4,142 |
| 99232 Hospital E&M - Subsequent | Facility | 278 | 118 | $62.32 | $17K |
| 87481 Infectious Agent Detection by DNA/RNA | Office | 175 | 31 | $34.39 | $6,018 |
| 99213 Office E&M - Established | Office | 161 | 140 | $56.29 | $9,062 |
| 87801 Infectious Agent Detection by DNA/RNA | Office | 138 | 38 | $57.83 | $7,980 |
| 99223 Hospital E&M - Initial | Facility | 57 | 55 | $140.73 | $8,022 |
| 87653 Infectious Agent Detection by DNA/RNA | Office | 35 | 31 | $34.39 | $1,204 |
| 87500 Infectious Agent Detection by DNA/RNA | Office | 35 | 31 | $34.39 | $1,204 |
| 87640 Infectious Agent Detection by DNA/RNA | Office | 35 | 31 | $34.39 | $1,204 |
| 87641 Infectious Agent Detection by DNA/RNA | Office | 35 | 31 | $34.39 | $1,204 |
| 87651 Infectious Agent Detection by DNA/RNA | Office | 35 | 31 | $34.39 | $1,204 |
By year: 2022 $332K for 8,843 services; 2023 $341K for 8,660 services; 2024 $254K for 6,268 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87798 Infectious Agent Detection by DNA/RNA | 455 | 31 | $34.39 | $16K |
| 81002 Clinical Chemistry | 344 | 259 | $3.41 | $1,173 |
| 87481 Infectious Agent Detection by DNA/RNA | 175 | 31 | $34.39 | $6,018 |
| 87801 Infectious Agent Detection by DNA/RNA | 138 | 38 | $57.83 | $7,980 |
| 87641 Infectious Agent Detection by DNA/RNA | 35 | 31 | $34.39 | $1,204 |
| 87651 Infectious Agent Detection by DNA/RNA | 35 | 31 | $34.39 | $1,204 |
| 87653 Infectious Agent Detection by DNA/RNA | 35 | 31 | $34.39 | $1,204 |
| 87640 Infectious Agent Detection by DNA/RNA | 35 | 31 | $34.39 | $1,204 |
| 87500 Infectious Agent Detection by DNA/RNA | 35 | 31 | $34.39 | $1,204 |
Medicare prescription drug claims, 2024
In 2024, the drug Geoffrey J Bisignani prescribed most often to Medicare patients was Orgovyx (Relugolix), with 947 prescriptions and refills. In total Geoffrey J Bisignani wrote 3,646 Medicare prescriptions that cost $11.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Orgovyx Relugolix | 947 | 947 | 112 | $2.4M |
| Xtandi Enzalutamide | 669 | 669 | 71 | $8.9M |
| Tamsulosin Hcl Generic | 580 | 1,558 | 228 | $14K |
| Finasteride Generic | 428 | 1,239 | 162 | $5,657 |
| Ciprofloxacin Hcl Generic | 98 | 98 | 88 | $200 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 97 | 97 | 89 | $116 |
| Silodosin Generic | 83 | 126 | 19 | $5,129 |
| Levofloxacin Generic | 81 | 81 | 68 | $105 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 74 | 74 | 66 | $129 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 59 | 119 | 17 | $1,178 |
| Solifenacin Succinate Generic | 47 | 91 | 17 | $6,118 |
| Myrbetriq Mirabegron | 46 | 94 | 18 | $40K |
| Oxybutynin Chloride Generic | 44 | 60 | 29 | $257 |
| Cephalexin Generic | 36 | 42 | 28 | $135 |
| Dutasteride Generic | 34 | 102 | 12 | $1,412 |
Brand drugs: 1,742 claims; generic drugs: 1,904 claims; opioid claims: 86.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Geoffrey J Bisignani $1,126 ($1,126 in general payments such as food, travel and fees) from 20 companies. The largest payer was Sumitomo Pharma America, Inc. with $247.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 24 | $247 |
| Janssen Biotech, Inc. JNJ | 10 | $146 |
| Astellas Pharma US Inc 4503.T | 7 | $129 |
| Procept Biorobotics Corporation PRCT | 3 | $91.57 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $72.1 |
| Verity Pharmaceuticals Inc. | 2 | $51.79 |
| Olympus America Inc. | 2 | $46.16 |
| Tolmar, Inc. | 2 | $45.06 |
| Cook Medical LLC | 1 | $40.11 |
| Ferring Pharmaceuticals Inc. | 2 | $39.48 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.